Navigation Links
First Implantable artificial heart gets FDA’s approva

The first completely implantable artificial heart was approved by the U.S. Food and Drug Administration (FDA) on Tuesday.// The artificial heart has been approved for patients with severe heart problem, who are too ill for a heart transplant.

Under the FDA's Humanitarian Use Device provisions, the device, the AbioCor Implantable Replacement Heart, was approved. However, it restricts the use of more than 4,000 units of any device per year. The usage of this artificial heart is restricted to people with acute heart failure who cannot accept a heart transplant and are not likely to live for more than a month.

“We're talking about a small group of end-stage patients, whose choice is between immediate death or new, innovative technology,” said Dr. Daniel Schultz, director of the FDA's Center for Devices and Radiological Health.

Abiomed Inc. of Danvers, Mass. produced this replacement heart.
"This is an important step in this type of technology. We hope this approval will encourage the continued refinement and improvement of this technology," he said.
The clinical trial was conducted on 14 men who finally died.

"The device extended survival for an average of 4.5 months, allowing the patients to spend valuable time with family and friends," said Dr. Bram Zuckerman, director of the FDA's Division of Cardiovascular Devices. "In two cases, lives were extended by 10 and 17 months, respectively. One patient was discharged from the hospital."

The patient’s own heart is replaced by this device, which is a 2-pound mechanical heart. A power transfer coil charges the system across the skin and recharges the internal battery. A controller and an internal battery are implanted in the patient’s abdomen.

The functions of the controller are to monitor and control the device and also its pumping rate. The patient can be free from external connections for up to an hour because of the internal battery. There ar e 2 external batteries also in this system that permit the patient to freely move for about 2 hours. Plugging into an electrical outlet while the batteries are being recharged can charge the system.

The size of the device permits it to be implanted only in people who are at least 6 feet tall and weigh at least 170 pounds, Zuckerman said. Hence, it may not be of use to most women.

Patients, who get the device implanted in them, will be under scrutiny with the ultimate aim of artificial heart devlopment that can replace heart transplant in all cases. "Those individuals [who get this device] are really pioneers in trying to develop this technology," Zuckerman said. "Hopefully, down the road it will be a better technology and more affordable. Without those people who volunteer to participate in this program, the development of this kind of technology for all of us wouldn't be possible."

Around $250,000 will be the cost of the device and whether insurance will cover the costs is not clear, Shultz said.

A post-market review of the device will be carried out by the manufacturer at 10 places in the U.S. as a part of the FDA approval. The use and safety of the device will be assessed by the study and this will pave way for further improvements.

Though it is a revolution in technology it won't replace heart transplants, says an expert.

"This will not supplant heart transplantation from human donors, which has many advantages over the artificial heart," said Dr. Byron K. Lee, an assistant professor of cardiology at the University of California, San Francisco. "Nevertheless, this will give those patients who do not qualify for traditional heart transplants an opportunity for improved quality of life."
YT
'"/>




Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. First human clone is near
4. First Artificial Heart patient has Major setback
5. First head-to-head trials of once weekly Fosamax and Actonel therapies
6. WHO Declares Vietnam First Country to Control SARS
7. Russia Reports First SARS Case
8. Hope for First New Melanoma Treatment in Decades
9. First global SARS meet opens
10. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
11. Hyderabad To Have Asia’s First Catheter Making Uni
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2016)... ... May 28, 2016 , ... May 26, 2016- In search of the K. ... theme event of “K Warriors” on June 4, 2016 at Ashbury Hotel and Suites ... is sponsored and hosted by Shaolin Institute and sanctioned by KSF (Kungfu Sanda Federation), ...
(Date:5/27/2016)... Columbia, SC (PRWEB) , ... May 27, 2016 , ... ... launched a line of classic American timber frame barn kits, which can be found ... are inspired by historic American barn plans, and they highlight the craftsmanship of ...
(Date:5/27/2016)... ... 2016 , ... With over 60 percent of acute stroke survivors being left ... to aid in the rehabilitation process has steadily increased. Ekso Bionics had been working ... due to stroke. , Ekso Bionics has now received clearance from the U.S. Food ...
(Date:5/27/2016)... Texas (PRWEB) , ... May 27, 2016 , ... ... satisfying Army body fat composition regulations. This is the first time that Coolsculpting ... normally screened at least every six months to ensure they meet the prescribed body-fat ...
(Date:5/27/2016)... ... May 27, 2016 , ... With a team ... and food industries. Aside from its GMP accreditation, Validation Center is also a ... certified products, services and staff. , Validation Center is ISO17025 accredited and only ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... NORTH CHESTERFIELD, Va. , May 25, 2016 ... commercially-available next-generation sequencing test for wounds and infections. ... fungi, ALL parasites, and select viruses. The test ... infected area. David G. ... advanced molecular testing to facilitate wound healing: "We ...
(Date:5/25/2016)... PUNE, India , May 25, 2016 /PRNewswire/ ... Pipeline Review, H1 2016"market research report that provides ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ...
(Date:5/24/2016)...   , Study met ... bowel cleansing and superiority in , ... of the ascending colon   ... Norgine B.V. today announced new positive data from the phase ... preparation) versus standard 2 litre PEG with ascorbate. The study met ...
Breaking Medicine Technology: